Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Esteban

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
Nucleos(t)ide analogue therapy: The role of tenofovir alafenamideMaria Buti, Cristina Marcos-Fosch, Rafael Esteban
Journal of Hepatology|August 25, 2015
Management of direct-acting antiviral agent failuresMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis BMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Journal of Hepatology|March 4, 2014
Reply to: "The importance of prognostic factors in cirrhosis"Macarena Simón-Talero, Rafael Esteban, Juan Córdoba
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
New therapeutic perspectives in HBV: when to stop NAsCristina Pérez-Cameo, Mònica Pons, Rafael Esteban
Medicina Clinica|July 2, 2011
[Quantification of hepatitis B virus HBsAg: clinical implications]Maria Buti, Francisco Rodríguez Frías, Rafael Esteban
The Journal of Infectious Diseases|November 21, 2017
Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B InfectionMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Clinics in Liver Disease|May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral HepatitisGeorge Papatheodoridis, Vasileios Lekakis, Rafael Esteban, et al.
Therapeutic Advances in Infectious Disease|February 22, 2021
Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis BLuisa Roade, Mar Riveiro-Barciela, Rafael Esteban, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypesMaria Buti, Francisco Rodriguez-Frias, Rosendo Jardi, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
Nucleos(t)ide analogue therapy: The role of tenofovir alafenamideMaria Buti, Cristina Marcos-Fosch, Rafael Esteban
Journal of Hepatology|August 25, 2015
Management of direct-acting antiviral agent failuresMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis BMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Journal of Hepatology|March 4, 2014
Reply to: "The importance of prognostic factors in cirrhosis"Macarena Simón-Talero, Rafael Esteban, Juan Córdoba
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
New therapeutic perspectives in HBV: when to stop NAsCristina Pérez-Cameo, Mònica Pons, Rafael Esteban
Medicina Clinica|July 2, 2011
[Quantification of hepatitis B virus HBsAg: clinical implications]Maria Buti, Francisco Rodríguez Frías, Rafael Esteban
The Journal of Infectious Diseases|November 21, 2017
Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B InfectionMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Clinics in Liver Disease|May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral HepatitisGeorge Papatheodoridis, Vasileios Lekakis, Rafael Esteban, et al.
Therapeutic Advances in Infectious Disease|February 22, 2021
Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis BLuisa Roade, Mar Riveiro-Barciela, Rafael Esteban, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypesMaria Buti, Francisco Rodriguez-Frias, Rosendo Jardi, et al.
Pageof 23